Biotech & Health

Eric Lefkofsky knows the public listing rodeo well and is about to enter it for a fourth time. The serial entrepreneur, whose net worth is estimated at nearly $4 billion, has already taken three businesses he’s founded public.  Today he’s the founder of Tempus, a genomic testing and data analysis company preparing to IPO. But

Fertility remains a pressing concern around the world — birthrates are down in many countries, and infertility rates (that is, the ability to conceive at all) are up. And given the emotional struggles people face when coping with infertility, it’s not surprising that the opportunity is so big. Yet equally so that the sector remains

U.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and data breach earlier this year.  In letters to affected individuals sent out this week, Cencora said that the data from its systems includes patient names, their postal address and date of